Xia Dong, Luo Xing, Zhu Youfeng, Zhu Jianqiu, Xie Yingqiu
Department of Intensive Care Unit, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, Guangdong, China.
Front Endocrinol (Lausanne). 2025 Mar 28;16:1496696. doi: 10.3389/fendo.2025.1496696. eCollection 2025.
The stress hyperglycemia ratio (SHR) is a new insulin resistance assessment tool for patients, which has been linked to clinical adverse events. We aimed to explore the SHR-mortality relationship in critically ill patients with sepsis.
Patients diagnosed with sepsis, along with blood glucose and hemoglobin A1c levels measured within 24 hours of admission, were retrospectively included in the analysis from the MIMIC-IV database between 2008 to 2019. Patients were stratified into quartile groups (quartile 1 (Q1) to quartile 4 (Q4)) according to SHR level, with 28-day mortality as the primary outcome. The SHR and short term mortality association in patients with sepsis was investigated via Cox regression and Kaplan-Meier analyses. The robustness of the results was verified via multivariate adjustments, multicollinearity, least absolute shrinkage and selection operator (LASSO), and the Boruta algorithm method. The complex relationships among the SHR, short-term mortality were estimated via restricted cubic spline (RCS) analyses.
2407 sepsis patients were involved, with a median age of 67 years, and 59.5% were male. Overall, 28-day, 60-day and 90-day mortality were 17.49% (n=421), 21.31% (n=513) and 23.89% (n=575), respectively. After adjusting confounding variables, the SHR was associated with greater short-term mortality, including 28-day (hazard ratio (HR)=1.14, 95% confidence interval (CI)=1.04-1.24, p=0.005; Q4 vs. Q1 (reference group), HR=1.41, 95% CI=1.06-1.87, p=0.017, p_trend=0.005), 60-day (HR=1.12, 95% CI=1.02-1.70, p=0.015; Q4 vs. Q1, HR=1.32, 95% CI=1.02-1.72, p=0.037, p_trend=0.021) and 90-day (HR=1.11, 95% CI=1.02-1.22, p=0.019; Q4 vs. Q1, HR=1.32, 95% CI=1.03-1.68, p=0.027, p_trend=0.017) mortality. Furthermore, the RCS analysis revealed a quasi U-shaped relationship with regards to SHR and short-term mortality in sepsis. The mortality rate increased with a SHR value larger or smaller than 0.9.
Our research revealed that SHR could serve as a novel indicator for predicting short-term mortality in sepsis patients. SHR demonstrated a quasi U-shaped relationship with short-term mortality in sepsis.
应激性高血糖比率(SHR)是一种针对患者的新型胰岛素抵抗评估工具,它与临床不良事件相关。我们旨在探讨脓毒症重症患者中SHR与死亡率的关系。
对2008年至2019年期间从MIMIC-IV数据库中回顾性纳入分析的确诊脓毒症患者,以及入院后24小时内测量的血糖和糖化血红蛋白水平进行研究。根据SHR水平将患者分为四分位数组(四分位数1(Q1)至四分位数4(Q4)),以28天死亡率作为主要结局。通过Cox回归和Kaplan-Meier分析研究脓毒症患者中SHR与短期死亡率的关联。通过多变量调整、多重共线性、最小绝对收缩和选择算子(LASSO)以及Boruta算法方法验证结果的稳健性。通过受限立方样条(RCS)分析估计SHR与短期死亡率之间的复杂关系。
共纳入2407例脓毒症患者,中位年龄为67岁,男性占59.5%。总体而言,28天、60天和90天死亡率分别为17.49%(n = 421)、21.31%(n = 513)和23.89%(n = 575)。在调整混杂变量后,SHR与更高的短期死亡率相关,包括28天(风险比(HR)= 1.14,95%置信区间(CI)= 1.04 - 1.24,p = 0.005;Q4与Q1(参照组),HR = 1.41,95% CI = 1.06 - 1.87,p = 0.017,p趋势 = 0.005)、60天(HR = 1.12,95% CI = 1.02 - 1.70,p = 0.015;Q4与Q1,HR = 1.32,95% CI = 1.02 - 1.72,p = 0.037,p趋势 = 0.021)和90天(HR = 1.11,95% CI = 1.02 - 1.22,p = 0.019;Q4与Q1,HR = 1.32,95% CI = 1.03 - 1.68,p = 0.027,p趋势 = 0.017)死亡率。此外,RCS分析显示脓毒症中SHR与短期死亡率呈准U形关系。当SHR值大于或小于0.9时,死亡率增加。
我们的研究表明,SHR可作为预测脓毒症患者短期死亡率的新指标。脓毒症中SHR与短期死亡率呈准U形关系。